Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
---|
CEO | Mr. Per Arthur Sørlie |
IPO Date | Oct. 18, 2012 |
Location | Norway |
Headquarters | Hjalmar Wessels vei 6 |
Employees | 1,127 |
Sector | Health Care |
Industries |
Borregaard ASA develops, produces, and markets specialized biomaterials, biochemicals, and biofuels in Norway, rest of Europe, the United States, Asia, and internationally. It operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for a range of applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and bioethanol. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Past 5 years
USD 18.25
USD 108.36
USD 12.08
USD 10.91
USD 8.65
StockViz Staff
January 15, 2025
Any question? Send us an email